270 related articles for article (PubMed ID: 15829534)
41. Topoisomerase II and leukemia.
Pendleton M; Lindsey RH; Felix CA; Grimwade D; Osheroff N
Ann N Y Acad Sci; 2014 Mar; 1310(1):98-110. PubMed ID: 24495080
[TBL] [Abstract][Full Text] [Related]
42. Potential role for DNA topoisomerase II poisons in the generation of t(11;20)(p15;q11) translocations.
Ahuja HG; Felix CA; Aplan PD
Genes Chromosomes Cancer; 2000 Oct; 29(2):96-105. PubMed ID: 10959088
[TBL] [Abstract][Full Text] [Related]
43. Identification of illegitimate recombination hot spot of the retinoic acid receptor alpha gene involved in 15;17 chromosomal translocation of acute promyelocytic leukemia.
Tashiro S; Kotomura N; Tanaka K; Suzuki K; Kyo T; Dohy H; Niwa O; Kamada N
Oncogene; 1994 Jul; 9(7):1939-45. PubMed ID: 8208541
[TBL] [Abstract][Full Text] [Related]
44. Clustering of genomic breakpoints at the MLL locus in therapy-related acute leukemia with t(4;11)(q21;q23).
Hasan SK; Barba G; Metzler M; Divona M; Ottone T; Cicconi L; Falini B; Mecucci C; Lo-Coco F
Genes Chromosomes Cancer; 2014 Mar; 53(3):248-54. PubMed ID: 24310817
[TBL] [Abstract][Full Text] [Related]
45. Intercalating TOP2 Poisons Attenuate Topoisomerase Action at Higher Concentrations.
Atwal M; Swan RL; Rowe C; Lee KC; Lee DC; Armstrong L; Cowell IG; Austin CA
Mol Pharmacol; 2019 Oct; 96(4):475-484. PubMed ID: 31399497
[TBL] [Abstract][Full Text] [Related]
46. [Mechanism of occurrence of secondary tumors by antitumor drugs].
Andoh T
Gan To Kagaku Ryoho; 1999 Nov; 26(13):1988-98. PubMed ID: 10584562
[TBL] [Abstract][Full Text] [Related]
47. Nucleotide-resolution mapping of topoisomerase-mediated and apoptotic DNA strand scissions at or near an MLL translocation hotspot.
Mirault ME; Boucher P; Tremblay A
Am J Hum Genet; 2006 Nov; 79(5):779-91. PubMed ID: 17033956
[TBL] [Abstract][Full Text] [Related]
48. Therapy-related acute promyelocytic leukaemia.
Bhavnani M; Azzawi SA; Yin JA; Lucas GS
Br J Haematol; 1994 Jan; 86(1):231-2. PubMed ID: 8011541
[TBL] [Abstract][Full Text] [Related]
49. Etoposide-related acute promyelocytic leukemia.
Kudo K; Yoshida H; Kiyoi H; Numata S; Horibe K; Naoe T
Leukemia; 1998 Aug; 12(8):1171-5. PubMed ID: 9697869
[TBL] [Abstract][Full Text] [Related]
50. Genotoxicity of dietary, environmental and therapeutic topoisomerase II poisons is uniformly correlated to prolongation of enzyme DNA residence.
Kalfalah FM; Mielke C; Christensen MO; Baechler S; Marko D; Boege F
Mol Nutr Food Res; 2011 May; 55 Suppl 1():S127-42. PubMed ID: 21520487
[TBL] [Abstract][Full Text] [Related]
51. Topoisomerase II is required for mitoxantrone to signal nuclear factor kappa B activation in HL60 cells.
Boland MP; Fitzgerald KA; O'Neill LA
J Biol Chem; 2000 Aug; 275(33):25231-8. PubMed ID: 10940316
[TBL] [Abstract][Full Text] [Related]
52. Secondary acute promyelocytic leukemia following chemotherapy for non-Hodgkin's lymphoma in a child.
Ogami A; Morimoto A; Hibi S; Todo S; Sugimoto T; Mori K; Imamura T; Ishida H; Yoshihara T; Iguchi A; Imaizumi M; Imashuku S
J Pediatr Hematol Oncol; 2004 Jul; 26(7):427-30. PubMed ID: 15218416
[TBL] [Abstract][Full Text] [Related]
53. Myeloperoxidase Enhances Etoposide and Mitoxantrone-Mediated DNA Damage: A Target for Myeloprotection in Cancer Chemotherapy.
Atwal M; Lishman EL; Austin CA; Cowell IG
Mol Pharmacol; 2017 Jan; 91(1):49-57. PubMed ID: 27974636
[TBL] [Abstract][Full Text] [Related]
54. Therapy-related acute myeloid leukemia secondary to inhibitors of topoisomerase II: from the bedside to the target genes.
Ratain MJ; Rowley JD
Ann Oncol; 1992 Feb; 3(2):107-11. PubMed ID: 1318741
[TBL] [Abstract][Full Text] [Related]
55. Topoisomerase II inhibitors induce DNA double-strand breaks at a specific site within the AML1 locus.
Stanulla M; Wang J; Chervinsky DS; Aplan PD
Leukemia; 1997 Apr; 11(4):490-6. PubMed ID: 9096688
[TBL] [Abstract][Full Text] [Related]
56. Acute promyelocytic leukemia with t(15;17) following inhibition of DNA topoisomerase II.
Pedersen-Bjergaard J
Ann Oncol; 1995 Oct; 6(8):751-3. PubMed ID: 8589010
[No Abstract] [Full Text] [Related]
57. Molecular biology of therapy-related leukaemias.
Joannides M; Grimwade D
Clin Transl Oncol; 2010 Jan; 12(1):8-14. PubMed ID: 20080465
[TBL] [Abstract][Full Text] [Related]
58. Environmental and chemotherapeutic agents induce breakage at genes involved in leukemia-causing gene rearrangements in human hematopoietic stem/progenitor cells.
Thys RG; Lehman CE; Pierce LC; Wang YH
Mutat Res; 2015 Sep; 779():86-95. PubMed ID: 26163765
[TBL] [Abstract][Full Text] [Related]
59. Therapy-related acute myelogenous leukemia associated with 11q23 chromosomal abnormalities and topoisomerase II inhibitors: report of four additional cases and brief commentary.
Bredeson CN; Barnett MJ; Horsman DE; Dalal BI; Ragaz J; Phillips GL
Leuk Lymphoma; 1993 Sep; 11(1-2):141-5. PubMed ID: 8220147
[TBL] [Abstract][Full Text] [Related]
60. Etoposide, topoisomerase II and cancer.
Baldwin EL; Osheroff N
Curr Med Chem Anticancer Agents; 2005 Jul; 5(4):363-72. PubMed ID: 16101488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
